Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test

11 Jan 2021 | 10:23 am | 1 min. read

Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.

The test, developed by German molecular diagnostics company GNA Biosolutions, has been approved by the domestic regulatory German Federal Institute for Drugs and Medical Devices (BfArM). The new PCR test, which produces a result in 40 minutes, is being rolled out across Germany with EU-wide approval expected in the coming months

The reliability of the rapid test system by GNA Biosolutions is comparable to common PCR tests, which, however, require up to 48 hours for a result.

The Pinsent Masons team advising on the deal was led by corporate partner Tobias Rodehau and included head of German public and regulatory Dr. Anke Empting, commercial and IP partner Dr. Michael Reich, technology, science and industry sector head Dr. Florian von Baum, head of German IP Marc Holtorf, and commercial legal director Dr. Igor Barabash.

Commenting on the project, Tobias Rodehau, said: "We are proud to have been able to assist GNA Biosolutions GmbH with this important project. Thanks to our expertise in the life sciences sector, we are familiar with the specifics of this industry and have been able to assemble a cross disciplinary team to play a role in facilitating swift access to this groundbreaking technology."

GNA Biosolutions GmbH is a long-standing client of Pinsent Masons. In 2019 the firm successfully advised the company on its USD 13.5 million Series C financing.

The Bavarian state government has acquired six GNA Biosolutions test devices, which were officially approved in December, as well as 60,000 test kits.

Meet the team

Show me all
Tobias Rodehau

Rechtsanwalt, Partner

Tobias specialises in small and mid-cap private equity transactions, with a focus on venture capital transactions.

Tobias Rodehau
Dr. Anke Empting

Rechtsanwältin, Partner, Head of German Public & Regulatory

Anke specialises in Public Commercial Law/Public Sector and has more than 10 years' experience in advising the public sector.

Dr Anke Empting
Dr. Florian von Baum

Rechtsanwalt, Partner, Sector Head Technology, Science & Industry

Florian is the Global Head of Technology, Science & Industry

von Baum Florian
Marc L. Holtorf

Rechtsanwalt, Partner, Head of German Intellectual Property

Marc Holtorf leads Pinsent Masons’ German Intellectual Property Group and the German Life Sciences sector. He specialises in supporting pharmaceutical, medical device and other high-tech companies in navigating through the complex world of contentious and non-contentious intellectual property.

Marc Holtorf

Key Contacts

Latest press releases

Show me all press releases

Pinsent Masons MPillay advises Ikigai Ventures Limited on its listing on the Official List (Main Board) of the London Stock Exchange

Multinational law firm Pinsent Masons MPillay has advised Ikigai Ventures Limited, a company acquiring target businesses that have a strong positive social impact and/or environmental, social and governance (ESG) strategy, on its admission to the Official List of the London Stock Exchange.

Pinsent Masons MPillay advises Fintech Asia Limited on its listing on the Official List (Main Board) of the London Stock Exchange

Multinational law firm Pinsent Masons MPillay has advised Fintech Asia Limited, a company acquiring target businesses in the fintech sector, on its admission to the Official List of the London Stock Exchange.

Pinsent Masons advises SOLA Group on renewable energy Power Purchase Agreement

Multinational law firm Pinsent Masons was appointed as sponsors legal counsel and advised South African energy company SOLA Group on its solar power initiative with Tronox, which will transform the manufacturing business’ electricity supply and support its 2050 net zero targets.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons MPillay advises Ikigai Ventures Limited on its listing on the Official List (Main Board) of the London Stock Exchange

Multinational law firm Pinsent Masons MPillay has advised Ikigai Ventures Limited, a company acquiring target businesses that have a strong positive social impact and/or environmental, social and governance (ESG) strategy, on its admission to the Official List of the London Stock Exchange.

Pinsent Masons MPillay advises Fintech Asia Limited on its listing on the Official List (Main Board) of the London Stock Exchange

Multinational law firm Pinsent Masons MPillay has advised Fintech Asia Limited, a company acquiring target businesses in the fintech sector, on its admission to the Official List of the London Stock Exchange.

Pinsent Masons hires corporate partner Francisco Aldavero in Spain

Multinational law firm Pinsent Masons has boosted its corporate capabilities with the hire of M&A and private equity partner Francisco Aldavero into its Madrid office.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts